z-logo
open-access-imgOpen Access
4CPS-141 Use of adalimumab in patients with hidradenitis suppurativa
Author(s) -
R. Fumero,
H Casas Aguado,
Sabrina Herrera,
MC Marín Guzmán,
J Cabeza Barrera
Publication year - 2018
Publication title -
section 4: clinical pharmacy services
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.232
Subject(s) - adalimumab , medicine , hidradenitis suppurativa , concomitant , adverse effect , retrospective cohort study , refractory (planetary science) , observational study , medical prescription , medical record , dermatology , surgery , tumor necrosis factor alpha , disease , pharmacology , physics , astrobiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom